Andrea Baldini։ Aspirin Prophylaxis Is Effective But Still Off-Label In Some Countries
Andrea Baldini, Instute Director at IFCA Clinic, shared The Bone and Joint Journal’s post on LinkedIn, adding:
”More and more high level evidence for an established prophylaxis which in my country is still considered ‘off label’…”
The Bone and Joint Journal, shared a post on LinkedIn about a recent article by Billy I. Kim, adding:
”The risk of thromboembolic events must be weighed against the increased potential for bleeding with more potent anticoagulants.”
Title: Aspirin prophylaxis is safe and effective for venous thromboembolism prophylaxis in low-risk patients undergoing aseptic revision total knee arthroplasty
Authors: Billy I. Kim, Brian P. Chalmers, Fred D. Cushner, Peter K. Sculco
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention